dual dopamine/serotonin receptor modulators (Wuhan Docan Pharmaceutical)

N/A

Report date: 2025/03/19 09:03:19
NME

Base Information

Drug Namedual dopamine/serotonin receptor modulators (Wuhan Docan Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsDopamine D2 receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBroad Medical Nutrition Science (Wuhan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBroad Medical Nutrition Science (Wuhan) Co Ltd
Inactive CompaniesN/A
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A